AZTherapies IPO

www.aztherapies.com

AZTherapies is a biopharmaceutical company developing novel small molecules and biologic therapies that aim to fundamentally change neurodegenerative disease progression, extending normal cognition and function and improving quality of life in the aging population.

Founded2011
Total Funding to Date$121.38MM
Register for Details

For more details on financing and valuation for AZTherapies, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

AZTherapies Ticker Symbol

AZTherapies does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

AZTherapies Stock Price

The stock price for AZTherapies will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

AZTherapies Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
8/28/2020 Series C-1 $401.38MM $XXX.XX $XXX.XX
10/7/2019 Series C $285.08MM $XXX.XX $XXX.XX
6/18/2018 Series B $225.39MM $XXX.XX $XXX.XX
11/20/2015 Series A and A-2 $157.32MM $XXX.XX $XXX.XX
12/22/2014 Series A-1 $69.29MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like AZTherapies in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B